Back
Speaker illustration

Doctor Wilfried Dinh

Boehringer Ingelheim, Ingelheim am Rhein (Germany)

Member of:

European Society of Cardiology

Presentations

A novel oral partial adenosine A1 receptor agonist for the treatment of heart failure: safety and tolerability in healthy volunteers pretreated with beta-blocker

Event: HEART FAILURE 2016

Topic: Drug therapy, other

Session: Drug therapy, other

Access
Like
Thumbnail

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources